Both ECOG score and cancer stage at diagnosis had highly significant p-values, <0.001 and 0.005, respectively.
← all excerpts
Comparison of Pneumonitis Rates and Severity in Patients With Lung Cancer Treated by Immunotherapy, Radiotherapy, and Immunoradiotherapy.
2
—
—
The sentences
Other variables that showed a trend with reduced odds of survival at 18 months of diagnosis but did not reach statistical significance were small cell lung cancer and advanced stage (II or III NSCLC or extensive SCLC).